Read More 1 minute read Health US Advisory Committee Moves to Ease Curbs on Popular but Unverified Peptides A US FDA advisory panel has voted to lower barriers for specialized pharmacies to produce controversial peptides like BPC-157 and KPV, despite significant concerns over a lack of human safety data. bygisthubJuly 24, 2026